Combined modality therapy of non-small cell lung cancers

Annals of Oncology

Volumn 10, Issue SUPPL. 6, 1999, Pages

  Juretic, Antonio ^a   Sobat, H ^a   Samija, M ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE; IRINOTECAN; TAXANE DERIVATIVE;

CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; LUNG NON SMALL CELL CANCER; METASTASIS; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; PRIORITY JOURNAL;

EID: 0033378568     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/10.suppl_6.S93     Document Type: Conference Paper

References (43)

1. Bonomi P, Keller SM, Wagner H Jr. Non-small-cell lung cancer. In: Pazdur R et al, eds. Cancer management: a multidisciplinary approach, 2nd ed. Huntington, NY: PRR, 1998: 329-51.
2. Goodman GE. Prevention of lung cancer. Curr Opin Oncol 1998; 10: 122-6.
3. Siegfried JM. Biology and chemoprevention of lung cancer. Chest 1998; 113: 40S-45S.
4. Carbone DP. The biology of lung cancer. Semin Oncol 1997; 24: 388-401.
5. CancerNet from the National Cancer Institute. Non-small cell lung cancer. Date last modified: 12/97.
6. CancerNet from the National Cancer Institute. Small cell lung cancer. Date last modified: 12/97.
7. Samija M, Sobat H, Juretic A et al. Suvremeni pristupi radioterapiji raka pluca. Libri Onkol 1996; 25 (suppl 1): 37-41.
8. Ruckdeschel JC. Future directions in non-small-cell lung cancer: a continuing perspective. Oncology 1998; 12 (suppl 2): 90-6.
9. Mountain C F. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-17.
10. Wagner H. Enhancing the role of radiotherapy in non-small cell lung cancer. Curr Opin Oncol 1998; 10: 139-45.
11. Feins RH. Surgery for early stage non-small cell lung cancer. Semin Oncol 1997; 24: 419-22.
12. Slotman BJ, Njo KH, Karim ABM. Curative radiotherapy for technically inoperable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1994; 29: 33-7.
13. Arriagada R. Current strategics for radiation therapy in non-small cell lung cancer. Chest 1997; 112: 209S-213S.
14. Non-small cell lung cancer collaborative group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 1995; 311: 899-909.
15. Perez CA, Stanley K, Rubin P et al. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat celt carcinoma of the lung. Cancer 1982; 50: 1091-9.
16. Emami B. Three-dimensional conformal radiation therapy in bronhogenic carcinoma. Semin Radiat Oncol 1996; 6: 92-7.
17. Werner-Wasik M, Curran WJ Jr. Optimizing nonoperative approaches to locally advanced non-small cell lung cancer. Adv Oncol 1997; 13: 10-6.
18. Rusch VW. Surgical treatment of patients with N2 disease. Semin Radiat Oncol 1996; 6: 76-85.
19. Ramanathan RK, Belani CP. Chemotherapy for advanced non-small cell lung cancer: past, present, and future. Semin Oncol 1997; 24: 440-54.
20. Dillman RO, Seagren SL. Propert KJ et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 1990; 323: 940-45.
21. Le Chevalier T, Arriagada R, Quoix E et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991; 83: 417-23.
22. Schaake-Koning C, Van Den Bogaert W, Dalesio O et al. Effect of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 1992; 326: 524-30.
23. Belani CP, Ramanathan RK. Combined-modality treatment of locally advanced non-small cell lung cancer. Incorporation of novel chemotherapeutic agents. Chest 1998; 113: 53S-60S.
24. Komaki R. Combined chemotherapy and radiation therapy in surgical unresectable regionally advanced non-small cell lung cancer. Semin Radiat Oneol 1966; 6: 86-91.
25. Ruckdeschel JC. Combined modality therapy of non-small cell lung cancer. Sem Oncol 1997; 24: 429-39.
26. Pass HI, Pogrebniak HW, Steinberg SM et al. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 1992; 53: 992-8.
27. Rosell R, Gomez-Codina J, Camps C et al. A randomized trial comparing preoperative chemotherapy and surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 1994; 330: 153-8.
28. Roth JA, Fosella F, Komaki R et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 1994; 86: 673-80.
29. Pisters KMW, Ginsberg RJ. Induction chemotherapy for early-stage non-small cell lung cancer. Adv Oncol 1997; 13: 25-9.
30. Natale RB. Experience with new chemotherapeutic agents in non-small cell lung cancer. Chest 1998; 113: 32S-39S.
31. Choy H, Wallace LA III, DeVore RF III. Paclitaxel in combined-modality therapy for locally advanced non-small cell lung cancer. Adv Oncol 1997; 13: 17-24.
32. Le Chevalier T, Arriagada R, Quoix E et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma. Lung Cancer 1994; 10: S239-S52.
33. Johnson DH. Combined-modality therapy for unresectable, stage III non-small-cell lung cancer - caveat emptor or caveat venditor (editorial)? J Natl Cancer Inst 1996; 88: 1175-7.
34. Dillman RO, Herndon J, Seagren SL et al. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. J Natl Cancer Inst 1996; 88: 1210-5.
35. Le Chevalier T, Arriagada R, Tarayre M et al. Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma (letter). J Natl Cancer Inst 1992; 84: 52.
36. Mattson K, Holsti LR, Holsti P et al. Inoperable non-small cell lung cancer: radiation with or without chemotherapy. Eur J Cancer Clin Oncol 1988; 24: 477-82.
37. Trovo MG, Minatel E, Franchin G et al. Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1992; 24: 11-5.
38. Blanke C, Ansari R, Mantravadi R et al. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol. J Clin Oncol 1995; 13: 1425-9.
39. Marino P, Preatoni A, Cantoni A. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb non-small cell lung cancer. A meta-analysis. Cancer 1995; 76: 593-601.
40. Sause WT, Scott C, Taylor S et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 1995; 87: 198-205.
41. Jeremic B, Shibamoto Y, Acimovic L et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study. J Clin Oncol 1996; 14: 1065-70.
42. Depiere A. An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer. Presented at 8th World Conference on Lung cancer; August, 1977; Dublin.
43. Splinter TAW, Smit E, Postmus P et al. A randomized trial of neoadjuvant chemotherapy followed by surgery versus surgery alone in patients with stage I, II and IIIA (N0) non-small cell lung cancer: preliminary analysis. Lung Cancer 1997, 18 (suppl 1): 66 (abstract).